From Real-World Data to Real-World Impact
Today’s environment is more specialized, competitive and cost-sensitive than ever before. Arcadia was built for just this challenge – not as a data aggregator, but as an evidence and activation partner. We connect directly to the health systems and provider networks where care happens, giving patients timely access to life-saving therapies and treatments.
The Challenge
For Life Sciences organizations, the path from innovation to impact is anything but simple. Data is fragmented. Patient journeys are incomplete. And the promise of precision medicine often stalls before reaching the point of care.
The Solution
Arcadia helps navigate that path, delivering real-world data with the depth, longitudinal continuity and care context needed to generate reliable evidence and improve patient outcomes
Arcadia Life Sciences Advantages
Data
- 150M+ patient records from EHR, claims, pharmacy, labs, social determinants
- 80% of patients tracked 5+ years
- Clinical NLP engine trained on 300M+ visits
- Direct provider connections, diverse care settings
- First-party access to Medicare and Medicaid data
Evidence
- Retrospective observational studies
- Comparative effectiveness research
- Health economics and outcomes modeling
- Patient identification and stratification
- Post-market surveillance and pharmacovigilance
Activation
- Precision health patient rosters
- Direct EHR integrations
- Email notification and care coordinator workflows
- Advanced NLP and multi-step validation
- Feedback loop from evidence to care; retroactive insights
Closing the Evidence-to-Action Gap
Arcadia has spent more than a decade building one of the most clinically rich healthcare performance platforms available. Our foundation is built from direct EHR connections to provider networks participating in value-based care. This is data from the care journey – and we activate that evidence back into front-line workflows where it makes the biggest impact on patient outcomes.
Our solutions are organized to address your most pressing RWD/RWE needs:
Research-ready clinical data
Comprehensive and curated datasets sourced from EHRs, claims, labs and pharmacy, with first-party access to Medicare/Medicaid populations
Why it matters: Data with depth and breadth supports high-cost, prevalent diseases -- like cardio, respiratory, metabolic and behavioral health – as well as highly tailored cohorts and registries, including rare diseases.
Longitudinal depth for research
80% of data has been tracked for 5+ years, with minimal gaps across care settings
Why it matters: Longitudinal data drives key RWE applications and research like retrospective studies, HEOR, post-market surveillance, synthetic arms control
RWE activation capability
Precision health infrastructure to deploy evidence directly into EHR workflows, email notifications and care coordinator rosters
Why it matters: This activation layer closes the gap between evidence generation and clinical impact – directly benefiting patients
Arcadia Attends ISPOR 2026
Arcadia participated in ISPOR 2026, showcasing real-world data solutions that support HEOR, RWE, and market access initiatives.
Leadership Team Expansion
Arcadia expanded its leadership team with the appointments of Chris Rallo, Sandy Leonard, and Amy Bagge-Smith.
Arcadia partners with HealthVerity
Arcadia partnered with HealthVerity to expand access to longitudinal patient data for life sciences research and commercial analytics.